Download PDF
Laryngorhinootologie 2016; 95(09): 620-626
DOI: 10.1055/s-0041-107558
Originalie
© Georg Thieme Verlag KG Stuttgart · New York

Stationäre Speicheldrüsenoperationen in Deutschland Eine DRG-basierte Analyse der Jahre 2007–2011

Inpatient Salivary Gland Surgery in Germany: A DRG-Based Nationwide Analysis, 2007–2011
J. E. Jensen
1   Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde, Universitätsklinikum Jena
,
P. Schlattmann
2   Institut für Medizinische Statistik, Informatik und Dokumentation, Universitätsklinikum Jena
,
O. Guntinas-Lichius
1   Klinik und Poliklinik für Hals-, Nasen-, Ohrenheilkunde, Universitätsklinikum Jena
› Author Affiliations
Further Information

Publication History

eingereicht 15 September 2015

akzeptiert 28 September 2015

Publication Date:
15 December 2015 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Hintergrund: Es gibt bislang keine deutschlandweite epidemiologische Untersuchung zu Speicheldrüsenoperationen.

Methoden: Die bundesweite Diagnosis-Related Groups (DRG)-Statistik der Jahre 2007–2011 wurde ausgewertet hinsichtlich der Indikationen auf Basis der ICD-10-Codes. Es wurde Operationsraten pro 100 000 Personenjahre für beide Geschlechter und in Alterskohorten berechnet.

Ergebnisse: Die durchschnittlichen deutschlandweiten stationären Operationsraten 2007–2011 betrugen für Inzisionen an den Speicheldrüsen (OPS-Ziffer 5–260) 1,43 pro 100 000 Personen, für Exzisionen an den Speicheldrüsen (5–261) 2,06 pro 100 000, für Speicheldrüsenresektionen (5–262) 16,15 pro 100 000 und für äußere Inzisionen an den Speicheldrüsen (5–270) 0,43 pro 100 000. Für die genannten vier OPS-Ziffern betrugen die Operationsraten in absteigender Häufigkeit für gutartige Tumoren 10,08 pro 100 000, für Speicheldrüsenentzündungen (ohne Speichelsteine) 4,00 pro 100 000, für Speicheldrüsenmalignome 3,90 pro 100 000, und für Speichelsteine 2,09 pro 100 000. Eine signifikante Zunahme der Operationsraten über die Jahre war für bösartige und gutartige Tumoren sowie Speichelsteine zu beobachten. Die Operationsraten waren insgesamt am höchsten bei Patienten >60 Jahre. Es waren regionale Schwankungen der Operationsraten zwischen den Bundesländern zu erkennen.

Diskussion: Erstmalig werden Operationsraten für Eingriffe an Speicheldrüsen berichtet. Insbesondere Eingriffe wegen Speicheldrüsenmalignomen sind häufiger als erwartet. Trotz Einführung minimal-invasiver Verfahren erscheinen die Raten an Speicheldrüsenresektionen bei Sialadenitis und Sialolithiasis noch sehr hoch.

Abstract

Background: This is the first population-based analysis of inpatient salivary gland surgery across Germany.

Methods: Nationwide Diagnosis-Related Groups (DRG) statistics for 2007 to 2011 were analyzed regarding indications for salivary gland surgery based on ICD-10 codes. Age specific surgery rates were calculated for both sexes.

Results: Inpatient salivary gland surgical rates in 2007–2011 amounted for incisions (OPS [Classification of Operations and Procedures] code 5–260) 1.43 per 100 000 population, for excisions (5–261) 2.06 per 100 000, for salivary gland resections (5–262) 2.06 per 100 000, and for external incisions (5–270) 0.43 per 100 000. Regarding the mentioned four OPS codes, the surgical rates for benign tumors accounted to 10.08 per 100 000, for sialadenitis (without sialoliths) to 4.00 per 100 000, for malignant tumors to 3.90 per 100 000, and for sialolithiasis to 2.09 per 100 000. The increase of surgical rates from 2007 to 2011 was significant for malignant and benign tumors as well as for salivary stones. The surgical rates were highest for patients>60 years.

Discussion: Especially surgery for malignant tumors was more frequent than expected. In spite of the introduction of minimal invasive technique the rates for salivary gland resections in case of sialadenitis or sialolithiasis still seem to be high.

Schlüsselwörter

Diagnosis-Related Groups - Deutschland - Gl. parotis - Speicheldrüsentumoren - Sialolithiasis - Sialadenitis

Key words

diagnosis-related groups - Germany - parotid gland - salivary gland tumor - sialolithiasis - sialadenitis
 

  • Literatur

  • 1 McGurk M, Thomas BL, Renehan AG. Extracapsular dissection for clinically benign parotid lumps: reduced morbidity without oncological compromise. Br J Cancer 2003; 89: 1610-1613
    CrossrefPubMedGoogle Scholar
  • 2 Iro H, Zenk J, Koch M, Klintworth N. Follow-up of parotid pleomorphic adenomas treated by extracapsular dissection. Head Neck 2013; 35: 788-793
    Google Scholar
  • 3 Marchal F, Dulguerov P, Lehmann W. Interventional sialendoscopy. New Engl J Med 1999; 341: 1242-1243
    CrossrefPubMedGoogle Scholar
  • 4 Geisthoff UW. Sialendoscopy. HNO 2008; 56: 105-107
    CrossrefPubMedGoogle Scholar
  • 5 Kroll T, Finkensieper M, Hauk H, Guntinas-Lichius O, Wittekindt C. Sialendoscopy–learning curve and nation-wide survey in German ENT-departments. Laryngorhinootologie 2012; 91: 561-565
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Preuss SF, Guntinas-Lichius O. On the diagnosis and treatment of parotid gland tumors: Results of a nationwide survey of ENT hospitals in Germany. HNO 2006; 54: 868-874
    CrossrefPubMedGoogle Scholar
  • 7 Moeller K, Esser D, Boeger D, Buentzel J, Hoffmann K, Jecker P, Mueller A, Radtke G, Piesold JU, Schultze-Mosgau S, Finkensieper M, Bitter T, Guntinas-Lichius O. Parotidectomy and submandibulectomy for benign diseases in Thuringia, Germany: a population-based study on epidemiology and outcome. Eur Arch Otorhinolaryngol 2013; 270: 1149-1155
    CrossrefPubMedGoogle Scholar
  • 8 Stang A, Stausberg J. Inpatient management of patients with skin cancer in Germany: an analysis of the nationwide DRG-statistic 2005-2006. Br J Dermatol 2009; 161 (Suppl. 03) 99-106
    CrossrefPubMedGoogle Scholar
  • 9 Stang A, Merrill RM, Kuss O. Hysterectomy in Germany: a DRG-based nationwide analysis, 2005–2006. Dtsch Arztebl Int 2011; 108: 508-514
    PubMedGoogle Scholar
  • 10 Stang A, Merrill RM, Kuss O. Prevalence-corrected hysterectomy rates by age and indication in Germany 2005-2006. Arch Gynecol Obstet 2012; 286: 1193-1200
    CrossrefPubMedGoogle Scholar
  • 11 Guntinas-Lichius O, Wendt TG, Buentzel J, Esser D, Böger D, Mueller AH, Piesold JU, Schultze-Mosgau S, Schlattmann P, Schmalenberg H. Incidence, treatment, and outcome of parotid carcinoma, 1996-2011: a population-based study in Thuringia, Germany. J Cancer Res Clin Oncol 2015; 141: 1679-1688
    CrossrefPubMedGoogle Scholar
  • 12 Stennert E, Kisner D, Jungehuelsing M, Guntinas-Lichius O, Schröder U, Eckel HE, Klussmann JP. High incidence of lymph node metastasis in major salivary gland cancer. Arch Otolaryngol Head Neck Surg 2003; 129: 720-723
    PubMedGoogle Scholar
  • 13 Guntinas-Lichius O, Klussmann JP, Wittekindt C, Stennert E. Parotidectomy for benign parotid disease at a university teaching hospital: Outcome of 963 operations. Laryngoscope 2006; 16: 534-540
    PubMedGoogle Scholar
  • 14 Preuss SF, Klussmann JP, Wittekindt C, Drebber U, Beutner D, Guntinas-Lichius O. Submandibular gland excision: 15 years of experience. J Oral Maxillofac Surg 2007; 65: 953-957
    CrossrefPubMedGoogle Scholar
  • 15 Gillespie MB, Koch M, Iro H, Zenk J. Endoscopic-assisted gland-preserving therapy for chronic sialadenitis: a German and US comparison. Arch Otolaryngol Head Neck Surg 2011; 137: 903-908
    CrossrefPubMedGoogle Scholar
  • 16 Sigismund PE, Zenk J, Koch M, Schapher M, Rudes M, Iro H. Nearly 3,000 salivary stones: Some clinical and epidemiologic aspects. Laryngoscope 2015; 125: 1879-1882
    CrossrefPubMedGoogle Scholar
  • 17 Bjorndal K, Krogdahl A, Therkildsen MH, Overgaard J, Johansen J, Kristensen CA, Homøe P, Sørensen CH, Andersen E, Bundgaard T, Primdahl H, Lambertsen K, Andersen LJ, Godballe C. Salivary gland carcinoma in Denmark 1990–2005: outcome and prognostic factors. Results of the Danish Head and Neck Cancer Group (DAHANCA). Oral Oncol 2012; 48: 179-185
    CrossrefPubMedGoogle Scholar
  • 18 Grant DG, Bradley PT. Epidemiology of malignant salivary gland neoplasms. In: Guntinas-Lichius O, Bradley PJ. (eds.) Salivary Gland Disorders and Diseases: Diagnosis and Management. Stuttgart: Thieme; 2011
    Article in Thieme ConnectGoogle Scholar
  • 19 Boukheris H, Curtis RE, Land CE, Dores GM. Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States. Cancer Epidemiol Biomarker Prev 2009; 18: 2899-2906
    CrossrefPubMedGoogle Scholar
  • 20 Bjorndal K, Krogdahl A, Therkildsen MH, Overgaard J, Johansen J, Kristensen CA, Homøe P, Sørensen CH, Andersen E, Bundgaard T, Primdahl H, Lambertsen K, Andersen LJ, Godballe C. Salivary gland carcinoma in Denmark 1990–2005: a national study of incidence, site and histology. Results of the Danish Head and Neck Cancer Group (DAHANCA). Oral Oncol 2011; 47: 677-682
    CrossrefPubMedGoogle Scholar
  • 21 Grant GA, Bradley PT. Epidemiology of benign salivary gland neoplasms. In: Bradley PJ, Guntinas-Lichius O. (eds.). Salivary Gland Disorders and Diseases: Diagnosis and Management. Stuttgart: Thieme; 2011
    Article in Thieme ConnectGoogle Scholar
  • 22 Behrbohm H, Kaschke O, Nawka T. Hals-Nasen-Ohren-Heilkunde. Stuttgart: Thieme; 2009
    Google Scholar
  • 23 Thurner D, Grasl M, Riss D, Lecher P. HNO-Heilkunde: Ein symptomorientiertes Lehrbuch. Heidelberg: Springer; 2011
    CrossrefGoogle Scholar
  • 24 Pinkston JA, Cole P. Incidence rates of salivary gland tumors. Results from a population-based study. Otolaryngol Head Neck Surg 1999; 120: 834-840
    CrossrefPubMedGoogle Scholar
  • 25 Finkensieper M, Volk GF, Guntinas-Lichius O. Inflammatory salivary gland diseases. Laryngorhinootologie 2013; 92: 119-136 quiz 37
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Al-Nawas B, Beutner D, Geisthoff U, Naujoks C, Reich R, Schröder U, Sproll C, Teymoortash A, Ußmüller J, Vogl T, Wittekindt C, Zenk J, Guntinas-Lichius O. The new S2k AWMF guideline for the treatment of obstructive sialadenitis in commented short form. Laryngorhinootologie 2014; 93: 87-94
    Article in Thieme ConnectPubMedGoogle Scholar
  • 27 Rauch SD. Diseases of the salivary glands. Wien Med Wochenschr 1965; 115: 261-265
    PubMedGoogle Scholar
  • 28 Escudier MP, McGurk M. Symptomatic sialoadenitis and sialolithiasis in the English population, an estimate of the cost of hospital treatment. Br Dent J 1999; 186: 463-466
    CrossrefPubMedGoogle Scholar
  • 29 Williams MF. Sialolithiasis. Otolaryngol Clin North Am 1999; 32: 819-834
    CrossrefPubMedGoogle Scholar
  • 30 Mandel L. Salivary gland disorders. Med Clin North Am 2014; 98: 1407-1449
    CrossrefPubMedGoogle Scholar